Physician profile
Ithaar Derweesh
NPI 1003873720
$3,194.97
in general payments reported to CMS, 2019-2025
21 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $189 · 2021: $11.19 · 2022: $18.31 · 2023: $1,280 · 2024: $638 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,411 · Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,410.75 |
| Food and Beverage | $1,238.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,185.10 | 2019-2025 | |
| Telix Pharmaceuticals | $892.65 | 2023 | Illuccix |
| Urogen Pharma, INC. | $174.75 | 2024-2025 | |
| Histosonics, INC. | $171.60 | 2024 | |
| Janssen Biotech, INC. | $170.03 | 2022-2024 | Erleada |
| Ethicon US, LLC | $120.00 | 2023 | Surgiflo Hemostatic Matrix, Echelon Flex |
| Profound Medical Corp. | $72.62 | 2024 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $61.34 | 2019-2024 | Adstiladrin |
| Integra Lifesciences Corporation | $59.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baxter Healthcare | $57.35 | 2024 | Perclot |
| Bard Access Systems, INC. | $37.31 | 2019 | |
| Exelixis INC. | $35.54 | 2024 | Cabometyx |
| Merck Sharp & Dohme LLC | $32.85 | 2024 | Welireg, Keytruda |
| Procept Biorobotics Corporation | $31.27 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $23.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $22.93 | 2025 | |
| Travere Therapeutics, INC. | $20.43 | 2020 | |
| Pfizer INC. | $14.31 | 2024 | |
| Teleflex LLC | $11.19 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ithaar Derweesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.